Wu, C., Lin, Y., Chen, G., Chi, C., Carbone, D. P., & Chen, J. (1999). Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade. Nature Publishing Group.

Wu, C-W, Y-Y Lin, G-D Chen, C-W Chi, D P. Carbone, and J-Y Chen. Serum Anti-p53 Antibodies in Gastric Adenocarcinoma Patients Are Associated With Poor Prognosis, Lymph Node Metastasis and Poorly Differentiated Nuclear Grade. Nature Publishing Group, 1999.

Wu, C-W, et al. Serum Anti-p53 Antibodies in Gastric Adenocarcinoma Patients Are Associated With Poor Prognosis, Lymph Node Metastasis and Poorly Differentiated Nuclear Grade. Nature Publishing Group, 1999.